{"id":"70014d3c-fd7a-491c-a68a-89923a01aed2","kind":"news","code":"70014d3c-fd7a-491c-a68a-89923a01aed2","name":"Tushenzhihe completes Pre-Series A financing","nameBasis":"translated-title","summary":"On 2026-08-18, according to Xiniu Data, Tushenzhihe completed Pre-Series A financing for an undisclosed amount. Investors were Shanghai Qianjunce Consulting Management Partnership (Limited Partnership). The company is an AI protein design services provider.","description":"","country":null,"category":null,"originalName":"途深智合完成Pre-A轮融资","eventDate":"2026-08-18T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-19T05:58:27.912Z","englishUpdatedAt":"2026-10-20T18:31:05.446Z","reviewedAt":"2026-10-20T18:31:05.446Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"76761e70374299e05f44576324626a98f95896bc54e47b439eac540f02f6019d","companyId":"e87a35bd-374a-4173-a5e0-a6c1f395d3ba","foundedYear":null,"logoUrl":null,"originalText":"2026年8月18日，据烯牛数据报道，途深智合完成Pre-A轮融资，金额未披露。投资方为上海千钧策咨询管理合伙企业（有限合伙）。该公司为AI蛋白质设计服务商。","sources":[],"related":[{"id":"2353fd24-bebb-4a6a-8ecf-95f27e0f6a2f","kind":"institutions","code":"UB-I7285","name":"Shanghai Qianjunce Consulting Management Partnership (Limited Partnership)","nameBasis":"transliterated","summary":"Shanghai Qianjunce Consulting Management Partnership (Limited Partnership), a venture capital firm focused on technology investments.","description":"Shanghai Qianjunce Consulting Management Partnership (Limited Partnership), a venture capital firm focused on technology investments.","country":null,"category":null,"originalName":"上海千钧策咨询管理合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:00:21.506Z","englishUpdatedAt":"2026-10-15T18:35:34.902Z","reviewedAt":"2026-10-15T18:35:34.902Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"2a7905c128344c68e004059c4bcde24f6aca315626cad84c4e9a48d120092308","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/shanghai-qianjunce-consulting-management-partnership-limited-partnership"},{"id":"e87a35bd-374a-4173-a5e0-a6c1f395d3ba","kind":"companies","code":"UB-C1680","name":"Tushenzhihe","nameBasis":"transliterated","summary":"The company develops lightweight, controllable AI protein design models to reduce the difficulty, development time, and cost of new synthetic biological products and drugs","description":"The company develops lightweight, controllable AI protein design models to reduce the difficulty, development time, and cost of new synthetic biological products and drugs","country":"China","category":null,"originalName":"途深智合","eventDate":null,"website":"https://tsynbio.com/","sourceUpdatedAt":"2026-10-03T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:26:42.661Z","reviewedAt":"2026-10-20T18:26:42.661Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"cfed7e3eb1d7749965546d2aac9c15e89e094b1fe1a4576527b67ec3fbc482a0","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/tushenzhihe"}],"path":"/news/70014d3c-fd7a-491c-a68a-89923a01aed2","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Tushenzhihe","path":"/companies/tushenzhihe"}},"canonical":"https://uniquebase.ai/news/70014d3c-fd7a-491c-a68a-89923a01aed2"}